Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Clinical Breast Cancer|September 6, 2017
Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III TrialsAnna Batistatou, Vassiliki Kotoula, Mattheos Bobos, et al.
Plos One|March 29, 2013
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer casesAlexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, et al.
Breast Cancer Research and Treatment|July 3, 2016
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytesVassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri, et al.
Cancer Genomics & Proteomics|April 28, 2017
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast CancersSofia Levva, Vassiliki Kotoula, Ioannis Kostopoulos, et al.
Oncotarget|October 28, 2015
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trialsVassiliki Kotoula, Kyriakos Chatzopoulos, Sotiris Lakis, et al.
Cancer Genomics & Proteomics|October 30, 2019
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for TreatmentHelena Linardou, Vassiliki Kotoula, George Kouvatseas, et al.
Cancer Medicine|September 22, 2018
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapyMarinos Tsiatas, Konstantine T Kalogeras, Kyriaki Manousou, et al.
American Journal of Hematology|April 22, 2011
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 yearsEfstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hatjiharissi, et al.
Clinical Colorectal Cancer|August 13, 2019
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and BevacizumabGeorge Pentheroudakis, Leonidas Mavroeidis, Kyriaki Papadopoulou, et al.
Pageof 26